November 2013 Brain Care Ireland issues call for Mental Health Therapists to use Central Nervous System Software

Brain Care Ireland (BCI), was located in the Research and Innovation Centre in NUI Galway, and brings new Telemedicine technologies for Central Nervous System Disorders (CNSD) that includes Stroke, Traumatic Brain Injury, early Alzheimer’s, MCI, Psychiatry and Senior Mental Health in Ireland today.

A person with mild cognitive impairment (MCI) is at an increased risk of developing Alzheimer's or another dementia so early detection makes sense so we should can place person on the appropriate MCI  programme to offset the onset and progress of the disease by up to 5 years (ref Dr Arun Bokde TCD). This early intervention approach is supported by Neil of Trinity College (Prof Brian Lawlor, Prof Ian Robertson and Sabina Brennan) and has indicated that ‘’Even modest therapeutic advances that delay disease onset and progression could significantly reduce the global burden of the disease and the level of care required by patients.” Prof Lawlor research interests are in the early detection, diagnosis and treatment of Alzheimer's disease, the neurobiology and treatment of behavioural and psychological symptoms in dementia and mental disorders in the community dwelling elderly. The king’s College of London’s recent research finding that ‘Alzheimer’s Disease; Online brain training improves the lives of over 60’s.

So on the back of such endorsements we should be integrating this global validated programme as these Technologies are used in many countries especially in the Memory Clinics in America and are reimbursable through Medicare. We make this technology available to all those involved in AD especially the Alzheimer’s Association of Ireland. Care must be taken to differentiate between companies that have spend vast monies on validating their research and those companies that simply present games as the latter are not research based, do not have scientific standing nor are they directly monitored by professionals. These latter programmes have damaged legitimate programme that have proven to be of benefit in the eyes of Medical Institutes et al.

The major advantage of Telemdicine is that, in addition to no side effects as in prescription drugs, Telemedicine can cater for thousands upon thousands of patients at the same time, which is ideal to Ireland with no side effects, at a fraction of the pharmaceutical cost, utilizes little manpower; a huge advantage over traditional methods where time, staff and funding are in major shortage.

Contact Brain Care Ireland on 085 217 1800 or email james@braincare.ie (www.braincare.ie)

-Ends-